Shingles (Herpes Zoster) Vaccine Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine
Condition: Herpes Zoster Interventions: Biological: Recombinant Zoster Vaccine; Biological: Placebo; Biological: Zoster Vaccine Recombinant, Adjuvanted Sponsors: Wuhan BravoVax Co., Ltd.; Shanghai BravoBio Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2023 Category: Research Source Type: clinical trials
